HOME
.................................................
Manage the Axilla with Z11 Data
.................................................
Meeting Highlights
.................................................
ASBS Summary
.................................................
Next Generation MammoSite Multi-Lumen
.................................................
Accelerated Partial Breast Irradiation Tech Bulletin
.................................................
Literature Corner
................................................
Editors' Bios
Pamela Benitez, MD
Dr. Benitez is a general surgeon
focusing exclusively on diseases
of the breast and breast cancer
at William Beaumont Hospital in
Royal Oak, Michigan
Martin Keisch, MD
Dr. Keisch is a board-certified radiation oncologist at University of Miami Hospital and President of Cancer HealthCare Associates (CHCA)
|
Manage the Axilla with Z11 Data (mini consensus) Pat Whitworth MD, Director, Nashville Breast Center, Clinical Associate Professor of Surgery, Vanderbilt University
Findings from the American College of Surgeons
Oncology Group Z1011 trial have led many leading institutions to stop performing completion
axillary dissection in breast conservation patients
who have only one or two sentinel nodes with
micro- or macro-metastases. As has been the
case with all major practice-changing breast cancer
clinical trials, "Z11" has been welcomed by
some leaders in the field and rejected by others.
As with the moves away from radical mastectomy
after the NSABP B-04 trial and toward breast
conservation with the NSABP B-06 trial, time
will ultimately allow incorporation of the important
findings from ACOSOG Z11 into common
clinical practice.
Read More »
|
|
ASBS: Treatment Affects
Risk of DCIS Recurrence |
ASBS: Prophylactic
Mastectomy Good Even
Years Later |
A study found that women diagnosed with
DCIS who were treated with radiation therapy
after lumpectomy to surgically excise the DCIS
were less likely to have cancer recur in the
same breast compared to women who didn't
have radiation therapy after surgery.
Excision plus radiotherapy was associated with
a 10-year recurrence rate of 18% compared with 30% for surgery alone (P=0.01). Read More » |
Investigators surveyed patients who had
contralateral prophylactic mastectomy at the
Mayo Clinic from 1960 to 1993. All of the
women had unilateral breast cancer and a
positive family history.
An initial survey conducted was an average
of 10 years after prophylactic mastectomy
attracted responses from 583 women (J
Clin Oncol 2005; 23: 7849-7856). Read More » |
Joint AAPM and COMP |
Vancouver, BC |
July 31– August 4, 2011 |
BIC Annual Meeting |
Orlando, FL |
September 20–23, 2011 |
ASTRO Annual Meeting |
Miami, FL |
October 2–6, 2011 |
|